Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive network map of IL-17A signaling pathway. | J Cell Commun Signal | 2023 | 35838944 | PubTator, text mining | PubMed |
| Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide. | Arthritis Rheumatol | 2023 | 35819819 | PubTator, text mining | PubMed |
| Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy. | Front Immunol | 2022 | 36755812 | PubTator, text mining | PubMed |
| Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors. | Front Immunol | 2022 | 36713375 | PubTator, text mining | PubMed |
| Advances in immunotherapy modalities for atherosclerosis. | Front Pharmacol | 2022 | 36703734 | PubTator, text mining | PubMed |
| Crosstalk between fibroblasts and T cells in immune networks. | Front Immunol | 2022 | 36700220 | PubTator, text mining | PubMed |
| Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia. | Front Pharmacol | 2022 | 36699085 | PubTator, text mining | PubMed |
| Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment. | Front Oncol | 2022 | 36698392 | PubTator, text mining | PubMed |
| Comprehensive expression analysis with cell-type-specific transcriptome in ALS-linked mutant SOD1 mice: Revisiting the active role of glial cells in disease. | Front Cell Neurosci | 2022 | 36687517 | PubTator, text mining | PubMed |
| Macrophage scavenger receptors: Tumor support and tumor inhibition. | Front Oncol | 2022 | 36686729 | PubTator, text mining | PubMed |
| The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study. | Front Genet | 2022 | 36685922 | PubTator, text mining | PubMed |
| Improper preanalytical processes on peripheral blood compromise RNA quality and skew the transcriptional readouts of mRNA and LncRNA. | Front Genet | 2022 | 36685907 | PubTator, text mining | PubMed |
| Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression. | Front Immunol | 2022 | 36685556 | PubTator, text mining | PubMed |
| Combination of transcriptional biomarkers and clinical parameters for early prediction of sepsis indued acute respiratory distress syndrome. | Front Immunol | 2022 | 36685531 | PubTator, text mining | PubMed |
| A high interferon gamma signature of CD8+ T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer. | Front Immunol | 2022 | 36685525 | PubTator, text mining | PubMed |
| Urine-Based Detection of Biomarkers Indicative of Chronic Kidney Disease in a Patient Cohort from Ghana. | J Pers Med | 2022 | 36675700 | PubTator, text mining | PubMed |
| Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss. | Biomedicines | 2022 | 36672540 | PubTator, text mining | PubMed |
| Editorial: Metabolic conditions of chronic inflammatory diseases. | Front Immunol | 2022 | 36643914 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer. | Cancer Drug Resist | 2022 | 36627901 | PubTator, text mining | PubMed |
| Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective. | Front Immunol | 2022 | 36618414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=42